Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,502 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The TP53 gene, tobacco exposure, and lung cancer.
Toyooka S, Tsuda T, Gazdar AF. Toyooka S, et al. Among authors: tsuda t. Hum Mutat. 2003 Mar;21(3):229-39. doi: 10.1002/humu.10177. Hum Mutat. 2003. PMID: 12619108 Review.
Dose effect of smoking on aberrant methylation in non-small cell lung cancers.
Toyooka S, Suzuki M, Tsuda T, Toyooka KO, Maruyama R, Tsukuda K, Fukuyama Y, Iizasa T, Fujisawa T, Shimizu N, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: tsuda t. Int J Cancer. 2004 Jun 20;110(3):462-4. doi: 10.1002/ijc.20125. Int J Cancer. 2004. PMID: 15095316 No abstract available.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F; COAST-Y study group. Landewé RB, et al. Ann Rheum Dis. 2021 May 6:annrheumdis-2020-219717. doi: 10.1136/annrheumdis-2020-219717. Online ahead of print. Ann Rheum Dis. 2021. PMID: 33958326 Free article.
1,502 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page